Clinical trial

KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus…

NCT00132951 · Sanofi, Industry · Terminated

Key facts

NCT number NCT00132951
Title KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections
Official title A Randomized, Investigator Blinded, Multi-Center Clinical Study To Compare Patient Outcomes and Clinical Effectiveness of Telithromycin Versus Azithromycin in Outpatients With Lower Respiratory Tract Infections
Acronym KEYS
Lead sponsor Sanofi, Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Respiratory Tract Infections, Chronic Bronchitis, Pneumonia
Intervention type Drug
Interventions Telithromycin, Azithromycin
Enrollment 2,051
Start date Oct 1, 2004
Primary completion Sep 1, 2006
Completion Sep 1, 2006
First posted Aug 22, 2005
Last update posted Aug 27, 2009
Countries Canada, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies